speb/financial-data huggingface dataset:
ADN.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 39720000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 5303000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 5303000.00
ADN.TO income_statement (annual, 2025-12-31) — EBIT: 71553000.00
ADN.TO income_statement (quarterly, 2025-12-31) — EBIT: 56766000.00
ADN.TO income_statement (annual, 2025-12-31) — EBITDA: 73435000.00
ADN.TO income_statement (quarterly, 2025-12-31) — EBITDA: 57279000.00
ADN.TO cash_flow (annual, 2025-12-31) — End Cash Position: 4808000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 4808000.00
ADN.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -8744000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2762000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Fixed Assets Revaluation Reserve: 24345000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Fixed Assets Revaluation Reserve: 24345000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 27572000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 27572000.00
ADN.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 3618000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1417000.00
ADN.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -57669000.00
ADN.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -568000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -410000.00
ADN.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 568000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 410000.00
ADN.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 57669000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 52115000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 51917000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 51917000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 6256000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 6256000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 95510000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 95510000.00
ADN.TO income_statement (annual, 2025-12-31) — Gross Profit: 26525000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 6972000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1353000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1353000.00
ADN.TO income_statement (annual, 2025-12-31) — Interest Expense: 4020000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 1086000.00
ADN.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 4020000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1086000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Inventory: 3032000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 3032000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 470451000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 470451000.00
ADN.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -8521000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 522000.00
ADN.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2189000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
ADN.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 82780000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 82780000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 110009000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 110009000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 110009000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 110009000.00
ADN.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2189000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
ADN.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -570000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -172000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -6510000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
ADN.TO balance_sheet (annual, 2025-12-31) — Net Debt: 105899000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 105899000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 39720000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 48973000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 48973000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 39720000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Interest Income: -4020000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -1086000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1619000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -172000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1619000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -172000.00
ADN.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4020000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1086000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Net PPE: 88498000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 88498000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2011000.00
ADN.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
ADN.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 353488000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 353488000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 144294000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 144294000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 144294000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 144294000.00
ADN.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 15198000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4754000.00
ADN.TO income_statement (annual, 2025-12-31) — Normalized Income: 6741193.31
ADN.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 2250657.33
ADN.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 6823000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4622000.00
ADN.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -58237000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -58079000.00
ADN.TO income_statement (annual, 2025-12-31) — Operating Income: 13316000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Operating Income: 4241000.00
ADN.TO income_statement (annual, 2025-12-31) — Operating Revenue: 86956000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 21976000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 18286767.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 18286767.00
ADN.TO income_statement (annual, 2025-12-31) — Other Income Expense: 58237000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 52525000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Other Inventories: 2361000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Other Inventories: 2361000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 521865000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 521865000.00
ADN.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 2234000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 147000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Other Properties: 12730000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 12730000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Payables: 18868000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Payables: 18868000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 18868000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 18868000.00
ADN.TO income_statement (annual, 2025-12-31) — Pretax Income: 67533000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 55680000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ADN.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -6510000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
ADN.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3205000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 671000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 671000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Receivables: 9154000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 9154000.00
ADN.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 60431000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 15004000.00
ADN.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1882000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 513000.00
ADN.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -570000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -172000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 141134000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 141134000.00
ADN.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 1194000.00
ADN.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 10975000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2584000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Share Issued: 18286767.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 18286767.00
ADN.TO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
ADN.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
ADN.TO income_statement (annual, 2025-12-31) — Special Income Charges: 568000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 410000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 359744000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 359744000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 353488000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 353488000.00
ADN.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 16005193.31
ADN.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 15055657.33
ADN.TO income_statement (annual, 2025-12-31) — Tax Provision: 18560000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 15960000.00
ADN.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.27
ADN.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
ADN.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -3025000.00
ADN.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -121000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Assets: 633613000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 633613000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 469753000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 469753000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Debt: 110707000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 110707000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 359744000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 359744000.00
ADN.TO income_statement (annual, 2025-12-31) — Total Expenses: 73640000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 17735000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 273869000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 273869000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 616619000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 616619000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 254303000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 254303000.00
ADN.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 13316000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 4241000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1353000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1353000.00
ADN.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 58237000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 52525000.00
ADN.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 58237000.00
ADN.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 52525000.00
ADN.TO balance_sheet (annual, 2025-12-31) — Working Capital: -2572000.00
ADN.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -2572000.00
ADN.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 3210000.00
ADN.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 23412000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9517000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 7376000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -7519000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 18426695.00
ADN.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.19
ADN.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4808000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 169466000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2269000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2269000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2588000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -2744000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -74000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 279000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -656000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 472000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2696000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1778000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1102000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 1778000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2539000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 169466000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2588000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 361534000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 15894000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 13333000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 711000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 711000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 15611000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1397000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1397000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 478000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 478000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 18426695.00
ADN.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.19
ADN.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3471000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 5352000.00
ADN.TO income_statement (quarterly, 2026-03-31) — EBIT: 5964000.00
ADN.TO income_statement (quarterly, 2026-03-31) — EBITDA: 6442000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 2269000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2744000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Fixed Assets Revaluation Reserve: 24345000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 28470000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 279000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 8000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -8000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1664000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 52815000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6243000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 96225000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 7518000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 31000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 1096000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1096000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 3688000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 473474000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -74000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 83336000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 111229000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 111229000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -156000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 109671000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3471000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3471000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -1096000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -156000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -156000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1096000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -74000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 88706000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 355291000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 145216000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 145216000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4786000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 2290232.54
ADN.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 279000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 8000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Operating Income: 4308000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 23412000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18455847.00
ADN.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 1656000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Other Inventories: 3688000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1664000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 525308000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 12889000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Payables: 14900000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 14900000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 4868000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 7376000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 15894000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 478000.00
ADN.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -156000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 139253000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3209000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 18455847.00
ADN.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -8000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 361534000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 355291000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 475232.54
ADN.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 1397000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
ADN.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -2309000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 633590000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 472763000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 111940000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 361534000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 19104000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 272056000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 620257000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 256445000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 4308000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 31000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1656000.00
ADN.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1656000.00
ADN.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -2278000.00
ADN1.DE income_statement (annual, 2021-12-31) — +Operating Expense: 155797000.00
ADN1.DE income_statement (annual, 2021-12-31) — +Total Revenue: 678324000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Accounts Payable: 28209000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Accounts Receivable: 120000000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -32857000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 52728000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 2808000.00
ADN1.DE income_statement (annual, 2021-12-31) — Basic Average Shares: 6258561.00
ADN1.DE income_statement (annual, 2021-12-31) — Basic EPS: 7.59
ADN1.DE cash_flow (annual, 2021-12-31) — Beginning Cash Position: 55053000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 127811000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Capital Expenditure: -18360000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 140403000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Capital Stock: 6503000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 109922000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 111474000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -3966000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Cash Equivalents: 24996000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Cash Financial: 84926000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -10058000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Change In Working Capital: -8393000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Changes In Cash: 55055000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Common Stock: 6503000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Common Stock Equity: 185158000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Common Stock Issuance: 48864000.00
ADN1.DE income_statement (annual, 2021-12-31) — Cost Of Revenue: 474558000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Assets: 283760000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 19318000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Debt: 20634000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 39952000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Liabilities: 179320000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Current Provisions: 12136000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Depreciation: 35998000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 35998000.00
ADN1.DE income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 35998000.00
ADN1.DE income_statement (annual, 2021-12-31) — Depreciation Income Statement: 35998000.00
ADN1.DE income_statement (annual, 2021-12-31) — Diluted Average Shares: 6275743.00
ADN1.DE income_statement (annual, 2021-12-31) — Diluted EPS: 7.57
ADN1.DE income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: 47501000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 249000.00
ADN1.DE income_statement (annual, 2021-12-31) — EBIT: 65932000.00
ADN1.DE income_statement (annual, 2021-12-31) — EBITDA: 101930000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: -186000.00
ADN1.DE cash_flow (annual, 2021-12-31) — End Cash Position: 109922000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Financing Cash Flow: 32646000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Free Cash Flow: 29552000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -17886000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 9000.00
ADN1.DE income_statement (annual, 2021-12-31) — General And Administrative Expense: 6519000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Goodwill: 68446000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 91123000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Gross PPE: 197229000.00
ADN1.DE income_statement (annual, 2021-12-31) — Gross Profit: 203766000.00
ADN1.DE income_statement (annual, 2021-12-31) — Interest Expense: 2702000.00
ADN1.DE income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 2702000.00
ADN1.DE income_statement (annual, 2021-12-31) — Interest Income: 1002000.00
ADN1.DE income_statement (annual, 2021-12-31) — Interest Income Non Operating: 1002000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Interest Paid Cff: -2694000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Interest Received Cfi: 120000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Invested Capital: 242328000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Investing Cash Flow: -25503000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 2808000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 48864000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 121085000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Long Term Debt: 36536000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 157621000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 4076000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Long Term Provisions: 3546000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 8166000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Minority Interest: 460000.00
ADN1.DE income_statement (annual, 2021-12-31) — Minority Interests: -76000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -5213000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 48864000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income: 47501000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 47501000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income Continuous Operations: 47577000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: 47501000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: 47501000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 63230000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: 47577000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1531000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Interest Income: -1700000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -2348000.00
ADN1.DE income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -1700000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 6225000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Net PPE: 164372000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -16780000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 94035000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 3505000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 4617000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 7881000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 999000.00
ADN1.DE income_statement (annual, 2021-12-31) — Normalized EBITDA: 85572000.00
ADN1.DE income_statement (annual, 2021-12-31) — Normalized Income: 35232500.00
ADN1.DE cash_flow (annual, 2021-12-31) — Operating Cash Flow: 47912000.00
ADN1.DE income_statement (annual, 2021-12-31) — Operating Income: 47969000.00
ADN1.DE income_statement (annual, 2021-12-31) — Operating Revenue: 678324000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 6503272.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Current Assets: 963000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 4059000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 22677000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Other Non Cash Items: 2651000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Non Current Assets: -1000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 3000.00
ADN1.DE income_statement (annual, 2021-12-31) — Other Operating Expenses: 40866000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Payable: 48310000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Properties: 61252000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Receivables: 48109000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 1552000.00
ADN1.DE income_statement (annual, 2021-12-31) — Other Special Charges: -18351000.00
ADN1.DE income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Payables: 102888000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5623000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Prepaid Assets: 1047000.00
ADN1.DE income_statement (annual, 2021-12-31) — Pretax Income: 63230000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Properties: 0.00
ADN1.DE cash_flow (annual, 2021-12-31) — Purchase Of Business: -17570000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1531000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Purchase Of Investment: -4187000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Purchase Of PPE: -16829000.00
ADN1.DE income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 474558000.00
ADN1.DE income_statement (annual, 2021-12-31) — Reconciled Depreciation: 35998000.00
ADN1.DE income_statement (annual, 2021-12-31) — Rent And Landing Fees: 450000.00
ADN1.DE income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 450000.00
ADN1.DE income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Retained Earnings: 126286000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 12357000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 0.00
ADN1.DE cash_flow (annual, 2021-12-31) — Sale Of Investment: 1839000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Sale Of PPE: 49000.00
ADN1.DE income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 5337000.00
ADN1.DE income_statement (annual, 2021-12-31) — Selling General And Administration: 11856000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Share Issued: 6503272.00
ADN1.DE income_statement (annual, 2021-12-31) — Special Income Charges: 16476000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Stockholders Equity: 185158000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Tangible Book Value: 94035000.00
ADN1.DE income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 4089500.00
ADN1.DE income_statement (annual, 2021-12-31) — Tax Provision: 15653000.00
ADN1.DE income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.25
ADN1.DE balance_sheet (annual, 2021-12-31) — Taxes Receivable: 2167000.00
ADN1.DE cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -28754000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Assets: 557203000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Capitalization: 221694000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Debt: 197573000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 185618000.00
ADN1.DE income_statement (annual, 2021-12-31) — Total Expenses: 630355000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 371585000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 273443000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 192265000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Total Tax Payable: 26369000.00
ADN1.DE income_statement (annual, 2021-12-31) — Total Unusual Items: 16358000.00
ADN1.DE income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 16358000.00
ADN1.DE balance_sheet (annual, 2021-12-31) — Working Capital: 104440000.00
ADN1.DE income_statement (annual, 2021-12-31) — Write Off: 1875000.00
ADN1.DE income_statement (annual, 2022-12-31) — +Operating Expense: 230625000.00
ADN1.DE income_statement (annual, 2022-12-31) — +Total Revenue: 900253000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 42333000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 172250000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -29612000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 49867000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 5187000.00
ADN1.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 6507846.00
ADN1.DE income_statement (annual, 2022-12-31) — Basic EPS: 4.40
ADN1.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 109922000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 122653000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -23953000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 137455000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 6512000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 90897000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 93793000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -4952000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Cash Equivalents: 0.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 90897000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -31211000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -35552000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -18405000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Common Stock: 6512000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -4952000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 210034000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 499000.00
ADN1.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 630739000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Assets: 339666000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 23047000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Debt: 55530000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 23047000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 214451000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Current Provisions: 7260000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Depreciation: 44759000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 44759000.00
ADN1.DE income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 44759000.00
ADN1.DE income_statement (annual, 2022-12-31) — Depreciation Income Statement: 44759000.00
ADN1.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 6524719.00
ADN1.DE income_statement (annual, 2022-12-31) — Diluted EPS: 4.38
ADN1.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 28603000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 171000.00
ADN1.DE income_statement (annual, 2022-12-31) — EBIT: 46595000.00
ADN1.DE income_statement (annual, 2022-12-31) — EBITDA: 91354000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -620000.00
ADN1.DE cash_flow (annual, 2022-12-31) — End Cash Position: 90897000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10979000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 12119000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
ADN1.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 90000.00
ADN1.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 16748000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Goodwill: 85814000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 124691000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 198928000.00
ADN1.DE income_statement (annual, 2022-12-31) — Gross Profit: 269514000.00
ADN1.DE income_statement (annual, 2022-12-31) — Interest Expense: 4513000.00
ADN1.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4513000.00
ADN1.DE income_statement (annual, 2022-12-31) — Interest Income: 410000.00
ADN1.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 410000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -3432000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Interest Received Cfi: 41000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 210034000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -43498000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 5187000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 499000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 114408000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 26578000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 114408000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 51000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 2578000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 4318000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 9355000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 5147000.00
ADN1.DE income_statement (annual, 2022-12-31) — Minority Interests: -190000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -14642000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 499000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income: 28603000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 28603000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 28793000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 28603000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 28603000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 42082000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 28793000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -5083000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Interest Income: -4103000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -5455000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 51000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 51000.00
ADN1.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -4103000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 18674000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Net PPE: 169316000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -18530000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 85343000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 5072000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 12044000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2816000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1250000.00
ADN1.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 83463000.00
ADN1.DE income_statement (annual, 2022-12-31) — Normalized Income: 23237120.00
ADN1.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 36072000.00
ADN1.DE income_statement (annual, 2022-12-31) — Operating Income: 38889000.00
ADN1.DE income_statement (annual, 2022-12-31) — Operating Revenue: 900253000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 6512272.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: 15695000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 6766000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 38877000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1565000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 717000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 54000.00
ADN1.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 65469000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Payable: 60565000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Properties: 66920000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 54537000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2896000.00
ADN1.DE income_statement (annual, 2022-12-31) — Other Special Charges: -926000.00
ADN1.DE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Payables: 138485000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6396000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 61000.00
ADN1.DE income_statement (annual, 2022-12-31) — Pretax Income: 42082000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Properties: 0.00
ADN1.DE cash_flow (annual, 2022-12-31) — Purchase Of Business: -990000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -5102000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -6634000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -18851000.00
ADN1.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 630739000.00
ADN1.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 44759000.00
ADN1.DE income_statement (annual, 2022-12-31) — Rent And Landing Fees: 328000.00
ADN1.DE income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 328000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Repayment Of Debt: 51000.00